Abstract:Abstract Background: Hepatitis B surface antigen (HBsAg) and viral load are important clinical indicators for patients with chronic hepatitis B (CHB) infection treated with antiviral therapy. Few studies have evaluated viral sequence biomarkers predicting the risk of hepatocellular carcinoma (HCC) in the stage, which show a low serological response (HBsAg <100 IU/ml) and high viral levels (HBV DNA >2,000 IU/ml). Additionally, point mutations within the pre S/S regions of HBsAg have frequently been reported to be associated with diagnostic failure, vaccine escape and immunotherapy escape. However, the prevalence of escape mutations with low levels of HBsAg (<100 IU/ml) in inactive HBsAg carriers has not been systematically studied within the past decade. Methods: This study aims to determine the trend of the biological prevalence of escape mutations within the pre S/S regions of special model of inactive CHB infection. Increased diversity over the complete HBV genome at baseline was associated with evolutionary characteristics. We used Sanger sequencing, quantitative HBV serology (HBeAg and HBsAg) and liver function index (aspartate alanine aminotransferase, ALT; alanine aminotransferase, AST) to identify whether HBV genome sequences are associated with the serological response to long-term host immunity in special inactive CHB infection.Results: Compared to HBV in HCC, HBV sequencing analysis of 28 LR/RA CHB patients with genotypes B and C showed higher genetic diversity among four ORFs, but the two groups presented similar selective pressure. Seven positive selection sites in the pre-S1 region are potentially associated with immune evasion. These mutations in the pre-S/S region might be associated with the HCC phenotype of low HBsAg expression, with the P region possibly impacting high viral loads.Conclusion: According to the results of this study, LR/RA CHB is characterized by not only genetic diversity but also positive evolutionary pressure within the pre-S/S regions. Increased viral diversity across the HBV genome is also associated with low levels of HBsAg. In conclusion, the cumulative evolutionary changes in the HBV pre-S/S regions that facilitate immune evasion should be monitored individually. Due to the similarity of evolutionary characteristics in HCC, low serological responses and high viremia may be associated with the risk of HCC.

Analysis of hepatitis B virus pre-C G1896A mutation in person with BeAg-negative chronic HBV infection

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Clinical Analysis of Hemopathy Patients with HBV Infection

Detecting of the Hepatic Fibrotic Indexes and Serous Markers from Patients with Chronic Hepatitis B (chb)and Variation of HBV DNA YMDD

Hepatitis B Virus Basal Core Promoter Mutations A1762T/G1764A Are Associated with Genotype C and a Low Serum HBsAg Level in Chronically-Infected HBeAg-positive Chinese Patients.

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

The Significance of United Mutations in Precore and BCP of HBV in Patients with HBeAg-negative Hepatitis B

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Prevalence of the Precore G1896A Mutation in Chinese Patients with E Antigen Negative Hepatitis B Virus Infection and Its Relationship to Pre-S1 Antigen.

T3098C and T53C Mutations of HBV Genotype C is Associated with HBV Infection Progress

Relationship between hepatitis B virus basic core promoter/precore mutations and viral genotypes

The Prevalence and Significance of HBV Basic Core Promoter/precore Mutations in Untreated Chronic Hepatitis B Patients

Evolutionary Analysis of Pre-S/S Mutations in HBeAg-Negative Chronic Hepatitis B with HBsAg < 100 IU/ml

Evolutionary analysis of pre S/S mutations in HBeAg-negative chronic hepatitis B with HBsAg <100 IU/ml

Prevalence of Basal Core Promoter and Precore Mutations in Chinese Chronic Hepatitis B Patients and Correlation with Serum HBeAG Titers

Hepatitis B Virus Genotypes, Precore Mutations, and Basal Core Promoter Mutations in HBV-infected Chinese Patients with Persistently Normal Alanine Aminotransferase and Low Serum HBV-DNA Levels

Hepatitis B Virus Mutations Associated with in Situ Expression of Hepatitis B Core Antigen, Viral Load and Prognosis in Chronic Hepatitis B Patients

Relationship among HBV Serum Markers, Pre-C 1896 Mutant and VirusLoading

Anti-HBe titre in patients infected with wild-type and eminus variant of hepatitis B virus

Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.